These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 25804229)
1. Redox-regulation of gelatinases during growth of cisplatin-sensitive and resistant Guerin carcinoma. Burlaka AP; Ganusevich II; Lozovska YV; Lukyanova NY; Chekhun VF Exp Oncol; 2015 Mar; 37(1):36-9. PubMed ID: 25804229 [TBL] [Abstract][Full Text] [Related]
2. Peculiarities of antioxidant system and iron metabolism in organism during development of tumor resistance to cisplatin. Chekhun VF; Lozovska YV; Burlaka AP; Lukyanova NY; Todor IN; Naleskina LA Exp Oncol; 2014 Sep; 36(3):196-201. PubMed ID: 25265354 [TBL] [Abstract][Full Text] [Related]
4. Superoxide- and NO-dependent mechanisms of antitumor and antimetastatic effect of L-arginine hydrochloride and coenzyme Q10. Burlaka AP; Ganusevich II; Golotiuk VV; Vovk AV; Lukin SМ Exp Oncol; 2016 Mar; 38(1):31-5. PubMed ID: 27031716 [TBL] [Abstract][Full Text] [Related]
5. Remodulating effect of doxorubicin on the state of iron-containing proteins, and redox characteristics of tumor with allowance for its sensitivity to cytostatic agents. Chekhun VF; Lozovska YV; Burlaka AP; Ganusevich LI; Shvets YV; Lukyanova NY; Todor IM; Tregubova NA; Naleskina LA Ukr Biochem J; 2016; 88(1):99-108. PubMed ID: 29227592 [TBL] [Abstract][Full Text] [Related]
6. Biodistribution analysis of cisplatin in liposomal form in animals with cisplatin-resistant and cisplatin-sensitive carcinoma. Nosko MM; Pivnyuk VM; Solyanik GI; Kulik GI; Todor IN; Momot VY; Melnikov OR; Ponomareva OV; Chekhun VF Exp Oncol; 2010 Mar; 32(1):40-3. PubMed ID: 20355294 [TBL] [Abstract][Full Text] [Related]
7. Effect of a prolonged superoxide flux on transferrin and ferritin. Paul T Arch Biochem Biophys; 2000 Oct; 382(2):253-61. PubMed ID: 11068877 [TBL] [Abstract][Full Text] [Related]
8. [Free oxygen radiacals and kidney diseases--part I]. Sakac V; Sakac M Med Pregl; 2000; 53(9-10):463-74. PubMed ID: 11320727 [TBL] [Abstract][Full Text] [Related]
10. Modifying effects of 5-azacytidine on metal-containing proteins profile in Guerin carcinoma with different sensitivity to cytostatics. Chekhun VF; Lozovska YV; Naleskina LA; Borikun TV; Burlaka AP; Todor IN; Demash DV; Yalovenko TM; Zadvornyi TV; Pavlova AO; Storchay DM; Lukianova NY Exp Oncol; 2016 Dec; 38(4):283-287. PubMed ID: 28230826 [TBL] [Abstract][Full Text] [Related]
11. O2*- and NO-associated mechanisms of selective action of redox-active cobalt complexes on tumor tissue. Ganusevich II; Burlaka AP; Sidorik EP; Levitin IY; Sigan AL; Osinsky SP Exp Oncol; 2007 Sep; 29(3):203-6. PubMed ID: 18004245 [TBL] [Abstract][Full Text] [Related]
12. [Influence of tumor drug resistance phenotype on the dynamics of cisplatin-induced changes of rat peripheral lymphocyte chromatin structure in Guerin's carcinoma]. Chekhun VF; Ganina KP; Kulik GI; Solianik GI; Kunskaia LN; Gushchenko NN Tsitol Genet; 2000; 34(5):11-7. PubMed ID: 11213624 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of ferritin-stimulated microsomal production of reactive oxygen intermediates by nitric oxide. Puntarulo S; Cederbaum AI Arch Biochem Biophys; 1997 Apr; 340(1):19-26. PubMed ID: 9126272 [TBL] [Abstract][Full Text] [Related]
14. Mechanisms of nitric oxide protection against tert-butyl hydroperoxide-induced cytotoxicity in iNOS-transduced human erythroleukemia cells. Yalowich JC; Gorbunov NV; Kozlov AV; Allan W; Kagan VE Biochemistry; 1999 Aug; 38(33):10691-8. PubMed ID: 10451363 [TBL] [Abstract][Full Text] [Related]
15. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes. Bitar MS; Wahid S; Mustafa S; Al-Saleh E; Dhaunsi GS; Al-Mulla F Eur J Pharmacol; 2005 Mar; 511(1):53-64. PubMed ID: 15777779 [TBL] [Abstract][Full Text] [Related]
16. High formation of superoxide anion and nitric oxide, and matrix metalloproteinases activity in vascular wall of rectal carcinoma vessels. Burlaka AP; Sidorik EP; Ganusevich II; Lestchenko YM; Burlaka AA; Osinsky SP Exp Oncol; 2006 Dec; 28(4):323-5. PubMed ID: 17285119 [TBL] [Abstract][Full Text] [Related]
17. ROS production by circulating phagocytes and Guerin carcinoma resistance to cisplatin. Prokhorova IV; Gorbach OI; Yakshibaeva YR; Shliakhtova NА; Solyanik GI Exp Oncol; 2021 Mar; 43(1):26-30. PubMed ID: 33785711 [TBL] [Abstract][Full Text] [Related]
18. [Effects of reactive species of oxygen and nitrogen on iron ion release from ferritin and synthesis of dinitrosyl iron complexes]. Shumaev KB; Zabbarova IV; Ruuge EK; Vanin AF Biofizika; 2003; 48(1):5-10. PubMed ID: 12630107 [TBL] [Abstract][Full Text] [Related]
19. Role of redox signaling and poly (adenosine diphosphate-ribose) polymerase activation in vascular smooth muscle cell growth inhibition by nitric oxide and peroxynitrite. Huang J; Lin SC; Nadershahi A; Watts SW; Sarkar R J Vasc Surg; 2008 Mar; 47(3):599-607. PubMed ID: 18295111 [TBL] [Abstract][Full Text] [Related]
20. [Changes in the free-radical state and level of free iron during the formation of drug resistance in tumor cells]. Saprin AN; Kalinina EV; Serezhenkov VA; Kotova IaN; Solomka VS; Shcherbak NP Biofizika; 2006; 51(3):485-90. PubMed ID: 16808348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]